Psychedelic drugs seem to offer hope as therapy for chronic depression, for which there have been few recent successes. How well do these drugs work, and what are their effects?
TORONTO, ON / ACCESSWIRE / October 7, 2021 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) ("GHP"), a Capital Pool Company listed on the TSX Venture Exchange (the "Exchange"), is pleased to
/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental.